AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia

Royal North Shore Hospital, St Leonards

The Alfred Hospital, Melbourne

The Royal Melbourne Hospital, Parkville

Northside Hospital, Atlanta

Universitaetsklinikum der Rheinisch-Westfaelischen Technischen Hochschule Aachen, Aachen

Universitaetsklinikum Bonn, Bonn

University of Chicago Hospital, Chicago

University Medical Center New Orleans, New Orleans

University of Texas MD Anderson Cancer Center, Houston

University of Colorado, Aurora

University of Utah Huntsman Cancer Institute, Salt Lake City

Universitaetsklinikum Ulm, Ulm

City of Hope National Medical Center, Duarte

University of California Davis Medical Center, Sacramento

Universitaetsklinikum Wuerzburg, Würzburg

Massachusetts General Hospital Cancer Center, Boston

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack

Tom Baker Cancer Centre, Calgary

University Health Network-Princess Margaret Cancer Centre, Toronto

National Hospital Organization Nagoya Medical Center, Nagoya

National Cancer Center Hospital East, Kashiwa-shi

National Hospital Organization Kyushu Cancer Center, Fukuoka

National Hospital Organization Okayama Medical Center, Okayama

NTT Medical Center Tokyo, Shinagawa-ku